The Osprey Study | Nucleus Network

8 nights

10 visits

This study is exploring a new potential treatment which is being considered for the management of immune responses to allergens and infections often associated with Asthma and other allergic diseases. This is crucial for understanding how the study drug behaves in the human body and if it can offer potential therapeutic effects for patients in the future.
The study medication will be administered for the first time in humans via an injection under the skin, which means there may be unknown risks. The study aims to determine if the drug can be safely used in this manner while adhering to strict safety standards. An independent ethics committee has approved this clinical trial.
This clinical trial has been carefully designed to minimise the risks for participants. Prior to participation you will be provided with detailed information about the trial, its risks and our mitigation strategies, and have an appointment with one of our doctors who will happily answer any questions that you may have.

Biological Sex Male or Female of non-childbearing potential

Age 18 - 65 years old

BMI 18-32 kg/m2

Weight >50kg

Medical History No significant medical history

Medications Not taking any medication

Smoking History Non-smokers